CAS: 29802-22-0; H-Pro-Nme2

该化合物是一种手性丙烯衍生物,其成分为碳箱酰胺功能组,对氮进行二甲基替代.由于合成化学和药用化学的立体特征,该化合物会影响对等选择性反应或作为生物活性分子的构件.二甲基酰胺会增强溶解性和稳定性,而二亚氨酯环则提供结构僵硬性,使其在电离层设计或作为药物前体有用.其定义明确的立体化学能确保需要精确分子互动的应用可再复制.该化合物通常在不成熟的条件下处理,以维护其完整性.

结构式图片

相似化合物

149596-90-7 433980-61-1 566159-08-8

欧盟法规

C&L通报

上下游产品

CAS号118916-60-2 (3R,7aS)-3-(tri... | CAS号124-40-3 二甲胺 | CAS号42718-55-8 (S)-benzyl 2-(d... | CAS号1148-11-4 N-CBZ-L-脯氨酸 | CAS号15761-39-4 B°C-L-脯氨酸 | CAS号147-85-3 脯氨酸 | CAS号29618-57-3 (S)-N,N-dimethy...

合成工艺路线路线简述

    📜N-苄氧羰基-L-脯氨酸置于palladium On Activated Charcoal N-羟基-7-氮杂苯并三氮唑,氢气,1-(3-二甲基氨基丙基)-3-乙基碳二亚胺体系中,用 甲醇,N,N-二甲基甲酰胺 用作溶剂,化学反应生成N,N-二甲基吡咯烷-2-甲酰胺
    参考文献:Structure-activity Relationships Of The Peptide Deformylase Inhibitor Bb-3497: Modification Of The P2' And P3' Side Chains
    标题:Structure-activity Relationships Of The Peptide Deformylase Inhibitor Bb-3497: Modification Of The P2' And P3' Side Chains
    摘要:Structural Modifications To The Peptide Deformylase Inhibitor Bb-3497 Are Described. In This Paper,We Describe The Initial Sar Around This Lead For Modifications To Both The P2' And P3' Side Chains. Enzyme Inhibition And Antibacterial Activity Data Revealed That A Variety Of Substituents Are Tolerated At The P2' And P3' Positions Of The Inhibitor Backbone. The Data From This Study Highlights The Potential For Modification At The P2' And P3' Positions To Optimise The Physicochemical Properties. (C) 2003 Elsevier Ltd. All Rights Reserved.
    Doi:10.1016/s0960-894X(03)00533-X

    海关参考信息

    专利信息


    专利号:US-6906046-B2
    优先权日:2000-12-22
    标题 :Pharmaceutical uses and synthesis of benzobicyclooctanes
    发明人:JACKSON RANDY W; DARWISH IHAB; BAUGHMAN TED A; HOWBERT J JEFFRY
    权利人:CELLTECH R & D INC
    摘要:Benzobicyclooctane compounds, their use in inhibiting cellular events involving TNF-α and IL-8, and in the treatment of inflammation events in general; a combinatorial library of diverse bicyclooctanes and process for their synthesis as a library and as individual compounds.

    专利号:US-8338620-B2
    优先权日:2007-04-03
    标 题:Methods for the production of C-8 lactam lactone compounds
    发明人:SEDELMEIER GOTTFRIED
    权利人:SEDELMEIER GOTTFRIED; NOVARTIS AG
    摘要:The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, the invention relates to a process for the manufacture of a compound of the formula I, n nor a salt thereof, wherein R1 as well as Act are as defined in the specification, and processes of manufacturing this compound as well as intermediates in this process.

    专利号:US-6797820-B2
    优先权日:1999-12-17
    标 题:Succinate compounds, compositions and methods of use and preparation
    发明人:PATEL DINESH; JACOBS JEFFREY W; JAIN RAKESH; NI ZHI-JIE; YUAN ZHENGYU
    权利人:VICURON PHARM INC
    摘要:Novel hydroxamic acid compounds are disclosed. These hydroxamates inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The hydroxymates are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as matrix metalloproteinases (MMPs). Methods of synthesis and of use of the compounds are also disclosed.

    专利号:US-2003069305-A1
    优先权日:2000-12-22
    标题:Pharmaceutical uses and synthesis of benzobicyclooctanes

    专利号:WO-02051851-A2
    优先权日:2000-12-22
    标题:Pharmaceutical uses and synthesis of benzobicyclooctanes

    专利号:RU-2198879-C2
    优先权日:1996-09-25
    标题:Derivatives of quinazoline, methods of their synthesis, pharmaceutical compositions comprising thereof, method of attainment of antiangiogenic effect and/or effect of blood vessel permeability reduction in warm-blooded animal

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Ochoa, C. I.; Tambar, U. K., Science of Synthesis Knowledge Updates, (2020) 2, 315.
    参考文献:10.1016/j.bmcl.2011.03.012
    摘要:Oost T, Backfisch G, Bhowmik S, van Gaalen MM, Geneste H, Hornberger W, Lubisch W, Netz A, Unger L, Wernet W. Potent and selective oxindole-based vasopressin 1b receptor antagonists with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 2011 Jun;21(12):3828–31. doi: 10.1016/j.bmcl.2011.03.012.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知